Surmodics Inc
NASDAQ:SRDX

Watchlist Manager
Surmodics Inc Logo
Surmodics Inc
NASDAQ:SRDX
Watchlist
Price: 39.58 USD 0.05%
Market Cap: 564.6m USD
Have any thoughts about
Surmodics Inc?
Write Note

Gross Margin
Surmodics Inc

73.8%
Current
80%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
73.8%
=
Gross Profit
93.1m
/
Revenue
126.1m

Gross Margin Across Competitors

Country US
Market Cap 564.7m USD
Gross Margin
74%
Country US
Market Cap 205.2B USD
Gross Margin
56%
Country US
Market Cap 193.1B USD
Gross Margin
67%
Country US
Market Cap 148.6B USD
Gross Margin
64%
Country US
Market Cap 132.9B USD
Gross Margin
69%
Country IE
Market Cap 109.9B USD
Gross Margin
65%
Country US
Market Cap 64.8B USD
Gross Margin
45%
Country DE
Market Cap 56.6B EUR
Gross Margin
38%
Country CN
Market Cap 326.2B CNY
Gross Margin
64%
Country US
Market Cap 42.2B USD
Gross Margin
79%
Country US
Market Cap 37.7B USD
Gross Margin
41%
No Stocks Found

Surmodics Inc
Glance View

Market Cap
564.7m USD
Industry
Health Care

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company is headquartered in Eden Prairie, Minnesota and currently employs 389 full-time employees. The firm operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.

SRDX Intrinsic Value
15.4 USD
Overvaluation 61%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
73.8%
=
Gross Profit
93.1m
/
Revenue
126.1m
What is the Gross Margin of Surmodics Inc?

Based on Surmodics Inc's most recent financial statements, the company has Gross Margin of 73.8%.